Skip to content

Pimethixene

RESPIRATORY SYSTEM

Also known as: calmixen, mepithiathene, pimethixene maleate, pimetixene

ATC R06AX23

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Pimethixene is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including Htr2a, SETD7 and luxR.

  • Molecular targets: Htr2a, SETD7 and luxR (3 listed in DrugCentral).
  • ATC code: R06AX23 (Other antihistamines for systemic use).
  • Molecular formula: C19H19NS; molecular weight 293.43 g/mol.

Mechanism & targets

Molecular targets (3)

TargetGeneActionActivity
5-hydroxytryptamine receptor 2AHtr2aunknownKi 8.60
Histone-lysine N-methyltransferase SETD7SETD7unknownIC50 5.37
Transcriptional activator protein luxRluxRunknownIC50 4.25

ATC classification

ATC codeTherapeutic hierarchy
R06AX23RESPIRATORY SYSTEM › ANTIHISTAMINES FOR SYSTEMIC USE › ANTIHISTAMINES FOR SYSTEMIC USE › Other antihistamines for systemic use

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Pimethixene is on its molecule page.

Molecular formulaC19H19NS
Molecular weight293.43 g/mol
CAS number314-03-4
InChIKeyNZLVRVYNQYGMAB-UHFFFAOYSA-N
PubChem CID4822
CN1CCC(CC1)=C1C2=CC=CC=C2SC2=C1C=CC=C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Pimethixene work?

Its molecular targets in DrugCentral include Htr2a, SETD7 and luxR.

What is the chemical formula of Pimethixene?

Pimethixene has the molecular formula C19H19NS and a molecular weight of 293.43 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets3
Indications0
FormulaC19H19NS
DrugCentral ID2169
Interactive profile